Phase I and pharmacologic study of intermittent twice-daily oral therapy with capecitabine in patients with advanced and/or metastatic cancer

M Mackean, AST Planting, C Twelves, JHM (Jan) Schellens, D Allman, B Osterwalder, B Reigner, T Griffin, SB Kaye, Jaap Verweij

Research output: Contribution to journalArticleAcademicpeer-review

257 Citations (Scopus)
Original languageUndefined/Unknown
Pages (from-to)2977-2985
Number of pages9
JournalJournal of Clinical Oncology
Volume16
Issue number9
Publication statusPublished - 1998

Research programs

  • EMC 04-01-DD-08-01

Cite this